aptitude
发表于 2025-3-28 17:02:51
https://doi.org/10.1007/978-981-10-8306-8is interest is ., which holds a unique position due to the early regulatory precedents established using this technology and also the diversity of materials it can process..To date, binder jetting is the only type of additive manufacturing worldwide to be part of an approved drug application, first
先行
发表于 2025-3-28 21:50:35
http://reply.papertrans.cn/15/1449/144826/144826_42.png
heterogeneous
发表于 2025-3-29 01:13:56
http://reply.papertrans.cn/15/1449/144826/144826_43.png
athlete’s-foot
发表于 2025-3-29 06:22:58
http://reply.papertrans.cn/15/1449/144826/144826_44.png
eustachian-tube
发表于 2025-3-29 07:57:31
Cryosurgery of Advanced External Cancerength, quality, and purity. Generally, the regulatory pathway to be followed in obtaining marketing authorization does not change with a manufacturing method employed in preparing a drug product or a device. New drug application can be submitted via 505(b)(1) or 505(b)(2) regulatory pathway, while a
anthesis
发表于 2025-3-29 15:13:16
http://reply.papertrans.cn/15/1449/144826/144826_46.png
MIME
发表于 2025-3-29 19:20:01
Subham BanerjeePresents applications, potential, and the challenges of additive manufacturing in pharmaceuticals.Discusses different aspects of pharmaceutical 3D printing platform technologies.Examines the regulator